Trending...
- CCHR Florida: Mental Health Awareness Month Open House
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE
- "Stop scrolling and start watching" - Beloved film recommendation site Criticker gets a major makeover
Honoring Dr. Morand for Exceptional Impact and Dedication to Advancing the Field of Lupus Research
The Evelyn V. Hess Award was established in 2006 and is given annually to recognize the outstanding contributions of a clinical or basic science researcher whose body of work has advanced the understanding of the science of lupus treatment.
Dr. Morand is Head of the School of Clinical Sciences at Monash University and Director of Rheumatology at Monash Health. His clinical research focuses on systemic lupus erythematosus (SLE), including clinical measurement, outcome predictors, and biomarkers. Dr. Morand founded the Monash Lupus Clinic, Australia's first multidisciplinary research-focused clinic for lupus. This laid the foundation for the Australian Lupus Registry and the Asia Pacific Lupus Collaboration, now among the largest longitudinal cohorts of SLE patients ever assembled.
He led the development of the Lupus Low Disease Activity State (LLDAS) treat-to-target endpoint, and currently leads an international consortium to redesign outcome measures for SLE trials. He was also principal investigator of the TULIP2 trial of the IFN receptor antibody anifrolumab, resulting in its regulatory approval for the treatment of SLE.
More on The PennZone
- Fairmint Introduces First Fully Onchain and Open Cap Table Infrastructure
- Vortex Brands Begins Gold Purchases Under New Joint Venture with Dubai-Based Partner
- Author Chandra Donelson Visits the Children's Museum of Pittsburgh
- Chandra Donelson Headlines the Hike2 Innovation Summit 2025
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Ushering in a Disruptive Innovation in Web3
"It's a great honor to receive the recognition of the Evelyn V. Hess Award from the Lupus Foundation of America and my peers, and it makes me want to redouble my efforts in our field," shared Dr. Morand. "As a physician for 30 years, I have observed how other autoimmune diseases have had incredible revolutions in treatment and patient outcomes, and the lack of a similar revolution in lupus in the same period affects me profoundly. However, we've seen great progress in recent years, and the bravery of our patients inspires me to do all I can to help the future of lupus be different from the past."
Honoring Dr. Joyce Chang for Notable Contributions
Established in 2009, the annual Mary Betty Stevens Young Investigator Prize recognizes the remarkable accomplishments of an investigator in the early stages of their lupus career and memorializes Dr. Stevens' outstanding contributions to lupus research throughout her career.
Dr. Joyce Chang, pediatric rheumatologist and Assistant Professor of Pediatrics at Boston Children's Hospital (BCH) and Harvard Medical School, has focused her research on cardiovascular health assessment and prevention in childhood-onset lupus. Very little is known about early cardiovascular disease in children, and Dr. Chang has diligently studied the use of non-invasive techniques to assess cardiac function and subclinical atherosclerosis in children with lupus. As a past winner of the LFA's Gary S. Gilkeson Career Development Award, Dr. Chang used the funding to identify novel screening tools for cardiovascular risk stratification in the pediatric population, including assessment of nocturnal blood pressure abnormalities and myocardial strain.
Dr. Chang has also led research in some of the most challenging problems in both pediatric and lupus care, including medication adherence, transition from pediatric to adult care, care quality, and health equity. She also co-leads a Transition Workgroup, and serves on the Diversity, Equity and Inclusion Committee in the Childhood Arthritis and Rheumatology Research Alliance.
More on The PennZone
- Aureli Construction Sets the Standard for Seamless Home Additions in Greater Boston
- Actuated Medical Launches Participating Preferred Series A Round, Led by Keiretsu Forum Mid-Atlantic, South-East, & Texas
- ScreenPoints Puts Film Investors in the Credits—and in the Money With New FinTech Platform
- Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
- Pathways to Adulthood Conference May 17 at Melville Marriott Honoring NYS Assembly Member Jodi Giglio, Suffolk County Legislator Nick Caracappa
"I have long looked up to the previous recipients of the Lupus Foundation of America's Mary Betty Stevens prize, and it's an honor to receive it," shared Dr. Chang. "I see so much potential in the children and teens that I care for. Some of them embrace living with lupus, while others still struggle. I want each of them to have the opportunity to reach their fullest potential, and whatever knowledge through research that can help us achieve that is worth pursuing."
During the event, recipients of the Evelyn V. Hess Award and Mary Betty Stevens Young Investigator Prize for 2021 and 2020 will also be honored as an awards reception was not held during those years due to the coronavirus pandemic.
About the Lupus Foundation of America
The Lupus Foundation of America is the national force devoted to solving the mystery of lupus, one of the world's cruelest, most unpredictable and devastating diseases, while giving caring support to those who suffer from its brutal impact. Through a comprehensive program of research, education, and advocacy, we lead the fight to improve the quality of life for all people affected by lupus. Learn more about the Lupus Foundation of America at lupus.org. For the latest news and updates, follow us on Twitter and Facebook.
Media Contact
Mike Donnelly
[email protected]
202-349-1155
SOURCE Lupus Foundation of America
Filed Under: Business
0 Comments
Latest on The PennZone
- ABM for Good™ Launches First Project with Build Change
- Braces for Teenagers in Allentown Offered by Exeter Smiles
- Roots for Boots to Host "Bike Day Bash" Featuring Trike Presentation to Local Veteran
- JOSHWAY Cuts Ribbon on New Brick-and-Mortar Location
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Children's Hospital of Philadelphia Researchers Recommend New Standard of Care for Families with Hereditary Neuroblastoma Linked to ALK Mutation
- GormanSquared Announces Provisional Patent
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- Chewy Chums™ Launches NeverBite™ on Kickstarter
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Fangzhou Launches Otsuka's Third-Generation Leukemia Drug Ponatinib on its Platform
- Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma